In the UK, although PSA testing is not currently recommended as a screening tool for prostate cancer [4], it is widely performed in primary care, either as a frontline test for men presenting with urinary tract/prostatic symptoms or as a free test for men aged ≥50 years at the request of the patient [5]. This evidence concerns the gene KLK3 and prostate carcinoma.